164 related articles for article (PubMed ID: 36974561)
41. Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy.
Carrieri MP; Pradier C; Piselli P; Piche M; Rosenthal E; Heudier P; Durant J; Serraino D
Int J Cancer; 2003 Jan; 103(1):142-4. PubMed ID: 12455069
[No Abstract] [Full Text] [Related]
42. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic.
Rabkin CS; Biggar RJ; Horm JW
Int J Cancer; 1991 Mar; 47(5):692-6. PubMed ID: 2004849
[TBL] [Abstract][Full Text] [Related]
43. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Multistate AIDS/Cancer Match Study Group.
Biggar RJ; Rosenberg PS; Coté T
Int J Cancer; 1996 Dec; 68(6):754-8. PubMed ID: 8980179
[TBL] [Abstract][Full Text] [Related]
44. AIDS--associated Kaposi's sarcoma: a rare entity at Maharaj Nakorn Chiang Mai Hospital.
Bhoopat SK; Vithayasai P; Pruksachatkunakorn C
Asian Pac J Allergy Immunol; 1996 Dec; 14(2):115-20. PubMed ID: 9177825
[TBL] [Abstract][Full Text] [Related]
45. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
46. AIDS and cancer registry linkage: measurement and enhancement of registry completeness. The National AIDS/Cancer Match Study Group.
Coté TR; O'Brien TR; Ward JW; Wilson SE; Blattner WA
Prev Med; 1995 Jul; 24(4):375-7. PubMed ID: 7479628
[TBL] [Abstract][Full Text] [Related]
47. Spectrum of AIDS-associated malignant disorders.
Goedert JJ; Coté TR; Virgo P; Scoppa SM; Kingma DW; Gail MH; Jaffe ES; Biggar RJ
Lancet; 1998 Jun; 351(9119):1833-9. PubMed ID: 9652666
[TBL] [Abstract][Full Text] [Related]
48. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.
Jones JL; Hanson DL; Dworkin MS; Jaffe HW
J Acquir Immune Defic Syndr; 2000 Jul; 24(3):270-4. PubMed ID: 10969352
[TBL] [Abstract][Full Text] [Related]
49. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study.
Ledergerber B; Telenti A; Egger M
BMJ; 1999 Jul; 319(7201):23-4. PubMed ID: 10390454
[No Abstract] [Full Text] [Related]
50. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.
Silverberg MJ; Lau B; Achenbach CJ; Jing Y; Althoff KN; D'Souza G; Engels EA; Hessol NA; Brooks JT; Burchell AN; Gill MJ; Goedert JJ; Hogg R; Horberg MA; Kirk GD; Kitahata MM; Korthuis PT; Mathews WC; Mayor A; Modur SP; Napravnik S; Novak RM; Patel P; Rachlis AR; Sterling TR; Willig JH; Justice AC; Moore RD; Dubrow R;
Ann Intern Med; 2015 Oct; 163(7):507-18. PubMed ID: 26436616
[TBL] [Abstract][Full Text] [Related]
51. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.
Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP;
Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354
[TBL] [Abstract][Full Text] [Related]
52. Marital status in relation to Kaposi's sarcoma, non-Hodgkin's lymphoma, and anal cancer in the pre-AIDS era.
Biggar RJ; Melbye M
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Feb; 11(2):178-82. PubMed ID: 8556400
[TBL] [Abstract][Full Text] [Related]
53. Epidemiology of AIDS-related tumours in developed and developing countries.
Dal Maso L; Serraino D; Franceschi S
Eur J Cancer; 2001 Jul; 37(10):1188-201. PubMed ID: 11423251
[TBL] [Abstract][Full Text] [Related]
54. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
[TBL] [Abstract][Full Text] [Related]
56. Trends and survival in AIDS-associated malignancies.
Casabona J; Salas T; Salinas R
Eur J Cancer; 1993; 29A(6):877-81. PubMed ID: 8484982
[TBL] [Abstract][Full Text] [Related]
57. Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome.
Biggar RJ; Curtis RE; Cote TR; Rabkin CS; Melbye M
Am J Epidemiol; 1994 Feb; 139(4):362-8. PubMed ID: 8109570
[TBL] [Abstract][Full Text] [Related]
58. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
59. The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ
Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
[TBL] [Abstract][Full Text] [Related]
60. Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?
Chaabna K; Bray F; Wabinga HR; Chokunonga E; Borok M; Vanhems P; Forman D; Soerjomataram I
Int J Cancer; 2013 Sep; 133(5):1197-203. PubMed ID: 23436712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
